Import and Manufacture of Rosiglitazone Banned

by Kathy Jones on  October 8, 2010 at 9:36 PM Drug News
RSS Email Print This Page Comment
Following the ban on rosiglitazone in Europe and the restricted access in the United States, the Indian government has imposed a ban on the import and manufacture of the diabetes drug in the country.
 Import and Manufacture of Rosiglitazone Banned
Import and Manufacture of Rosiglitazone Banned

People using rosiglitazone have experienced a number of serious side effects including cardiovascular events and adverse effects on lipid profile leading to its ban in Europe.

An Expert Committee on October 7 recommended a similar ban in India which was enforced with immediate effect.

The Drugs Controller General of India (DCGI) Dr Surinder Singh revealed that directives have been sent to state drugs controllers in the country regarding the suspension of licenses granted to manufacture for sale and distribution of the drug.




Source:

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
Notify me when reply is posted
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive